(Q43707054)

26 November 2017

title

Altered brain uptake of therapeutics in a triple transgenic mouse model of Alzheimer's disease (English)

1 reference

26 November 2017

0 references

Dharmini C Mehta

1

1 reference

26 November 2017

Jennifer L Short

series ordinal

2

1 reference

26 November 2017

Joseph A Nicolazzo

series ordinal

3

1 reference

26 November 2017

publication date

22 June 2013

1 reference

26 November 2017

published in

Pharmaceutical Research

1 reference

26 November 2017

volume

30

1 reference

26 November 2017

issue

11

1 reference

26 November 2017

page(s)

2868-2879

1 reference

The blood-brain barrier/neurovascular unit in health and disease

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1116-2

The blood-brain barrier in health and chronic neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1116-2

Cerebral microvascular pathology in aging and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1116-2

Increased collagen content of cerebral microvessels in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1116-2

Deposition of Alzheimer's beta-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1116-2

Soluble aggregates of the amyloid-beta protein selectively stimulate permeability in human brain microvascular endothelial monolayers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1116-2

Drug delivery to the brain in Alzheimer's disease: consideration of the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1116-2

Confounding parameters in preclinical assessment of blood-brain barrier permeation: an overview with emphasis on species differences and effect of disease states

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1116-2

Integrity of the blood-CSF barrier in dementia of Alzheimer type: CSF/serum ratios of albumin and IgG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1116-2

Permeability of the blood-brain barrier to albumin and insulin in the young and aged SAMP8 mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1116-2

Chylomicron amyloid-beta in the aetiology of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1116-2

Reduction of the cerebrovascular volume in a transgenic mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1116-2

Central nervous system penetration for small molecule therapeutic agents does not increase in multiple sclerosis- and Alzheimer's disease-related animal models despite reported blood-brain barrier disruption

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1116-2

Radioiodinated clioquinol as a biomarker for beta-amyloid: Zn complexes in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1116-2

Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1116-2

Predicting blood-brain barrier permeability of drugs: evaluation of different in vitro assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1116-2

Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1116-2

Assessment of blood-brain barrier permeability using the in situ mouse brain perfusion technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1116-2

Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1116-2

Methods to assess drug permeability across the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1116-2

Insulin detemir is not transported across the blood–brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1116-2

Impact of p-glycoprotein inhibition and lipopolysaccharide administration on blood-brain barrier transport of colistin in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1116-2

Frequency of stages of Alzheimer-related lesions in different age categories

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1116-2

Expression of drug transporters at the blood-brain barrier using an optimized isolated rat brain microvessel strategy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1116-2

In situ mouse carotid perfusion model: glucose and cholesterol transport in the eye and brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1116-2

Amyloid beta protein 1-40 and 1-42 levels in matched cerebrospinal fluid and plasma from patients with Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1116-2

Blood-brain barrier integrity in Alzheimer's disease patients and elderly control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1116-2

Blood-brain barrier permeability in Alzheimer's disease: a case-control MRI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1116-2

Ultrastructural features of the blood-brain barrier in biopsy tissue from Alzheimer's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1116-2

Vascular basement membrane pathology and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1116-2

Dendritic degeneration, neurovascular defects, and inflammation precede neuronal loss in a mouse model for tau-mediated neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1116-2

Brain microvascular changes in Alzheimer's disease and other dementias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1116-2

Changes in beta-adrenergic receptor subtypes in Alzheimer-type dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1116-2

Adrenergic receptors in aging and Alzheimer's disease: increased beta 2-receptors in prefrontal cortex and hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1116-2

Loss of functional GABA(A) receptors in the Alzheimer diseased brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1116-2

Restoring blood-brain barrier P-glycoprotein reduces brain amyloid-beta in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1116-2

Beta amyloid effects on expression of multidrug efflux transporters in brain endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1116-2

Tumor necrosis factor alpha and endothelin-1 increase P-glycoprotein expression and transport activity at the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1116-2

Lipopolysaccharide impairs blood-brain barrier P-glycoprotein function in mice through prostaglandin- and nitric oxide-independent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1116-2

Detailed immunohistochemical characterization of temporal and spatial progression of Alzheimer's disease-related pathologies in male triple-transgenic mice

21 January 2018

1 reference

12 December 2020

Brain perfusion systems for studies of drug uptake and metabolism in the central nervous system

1 reference

12 December 2020

Transport of drugs across the blood-brain barrier in Alzheimer's disease.

1 reference

12 December 2020

Blood-brain barrier permeability precedes senile plaque formation in an Alzheimer disease model

1 reference

12 December 2020

Alzheimer's disease: genes, proteins, and therapy

1 reference

12 December 2020

Amyloid-beta-induced occludin down-regulation and increased permeability in human brain endothelial cells is mediated by MAPK activation.

1 reference

12 December 2020

Blood-brain barrier permeability of the demented elderly as studied by cerebrospinal fluid-serum albumin ratio.

1 reference

12 December 2020

10.1007/S11095-013-1116-2

Identifiers

DOI

1 reference

26 November 2017

1 reference